Clinical Trials Directory

Trials / Completed

CompletedNCT02921698

Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment

Status
Completed
Phase
—
Study type
Observational
Enrollment
100 (actual)
Sponsor
Microvention-Terumo, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective, multicenter, observational evaluation of the safety and efficacy of the FRED® device in the treatment of intracranial aneurysms.

Conditions

Interventions

TypeNameDescription
DEVICEFRED®Flow Re-Direction Endoluminal Device

Timeline

Start date
2014-07-01
Primary completion
2017-02-01
Completion
2017-12-01
First posted
2016-10-03
Last updated
2018-05-17

Source: ClinicalTrials.gov record NCT02921698. Inclusion in this directory is not an endorsement.

Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment (NCT02921698) · Clinical Trials Directory